Three-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Felip Font, E. [1 ]
Gettinger, S. N. [2 ]
Burgio, M. A. [3 ]
Antonia, S. J. [4 ]
Holgado, E. [5 ]
Spigel, D. R. [6 ]
Arrieta, O. [7 ]
Domine Gomez, M. [8 ]
Aren Frontera, O. [9 ]
Brahmer, J. [10 ]
Chow, L. Q. [11 ]
Crino, L. [12 ]
Butts, C. [13 ]
Coudert, B. [14 ]
Horn, L. [15 ]
Steins, M. [16 ]
Geese, W. J. [17 ]
Li, A. [17 ]
Healey, D. [17 ]
Vokes, E. E. [18 ]
机构：
[1] Hosp Univ Vall dHebron, Thorac Tumors Grp, Barcelona, Spain
[2] Yale Canc Ctr, Oncol, New Haven, CT 06510 USA
[3] IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Oncol, Meldola, Italy
[4] H Lee Moffitt Canc Ctr & Res Inst, Oncol, Tampa, FL USA
[5] Hosp Madrid, Oncol, Norte Sanchinarro, Madrid, Spain
[6] Tennessee Oncol PLLC, Sarah Cannon Res Inst, Med Oncol, Nashville, TN 37203 USA
[7] Inst Nacl Cancerol, Oncol, Mexico City, DF, Mexico
[8] Fdn Jimenez Diaz, Oncol, Madrid, Spain
[9] Ctr Int Estudios Clin, Oncol, Santiago, Chile
[10] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Oncol, Baltimore, MD 21231 USA
[11] Univ Washington, Oncol, Seattle, WA 98195 USA
[12] Osped Perugia, Oncol, Perugia, Italy
[13] Cross Canc Inst, Oncol, Edmonton, AB, Canada
[14] Ctr Georges Francois Leclerc, Oncol, Dijon, France
[15] Vanderbilt Ingram Canc Ctr, Thorac Oncol, Nashville, TN 37232 USA
[16] Heidelberg Univ Hosp, Thoraxklin, Oncol, Heidelberg, Germany
[17] Bristol Myers Squibb, Immunooncol, Princeton, NJ 08540 USA
[18] Univ Chicago Med & Biol Sci, Oncol, Chicago, IL 60637 USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1301PD
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Wu, Y.
    Chang, J.
    Zhang, L.
    Tu, H.
    Wu, L.
    Feng, J.
    Lu, S.
    Zhou, C.
    Wang, J.
    Mok, T.
    Taylor, F.
    Mossman, B.
    Penrod, J.
    Lawrance, R.
    Blum, S.
    Wang, P. F.
    Cheng, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1047 - S1048
  • [42] Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
    Martinez Moreno, E.
    Irigoyen Medina, A.
    Martinez Barroso, K.
    Borregon Rivilla, M.
    Alvarez Cabellos, R.
    Cardenas, J. D.
    Andrade Santiago, J.
    Burgueno Lorenzo, I.
    Trujillo Alba, B.
    Chacon Lopez-Muniz, J. I.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2430 - S2430
  • [43] Frequency of follow-up brain imaging in non-small cell lung cancer (NSCLC) patients with previously treated brain metastases (BrMs)
    Milner-Watts, C.
    Perna, M.
    O'Brien, M.
    LUNG CANCER, 2020, 139 : S20 - S20
  • [44] Nivolumab in Second Line Non-Small Cell Lung Cancer - Comparing Real-World Outcomes in England to CheckMate (CM) 017 and 057
    Popat, S.
    Tanna, N.
    Hartridge-Lambert, S.
    Kiff, C.
    Sowdani, A.
    Rothwell, B.
    Henrik-Brodtkorb, T.
    Ling, C.
    Smittenaar, R.
    Bomb, M.
    Turnbull, A.
    Lawton, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S637 - S638
  • [45] Three-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: Pooled analysis of ONO-4538-05 and ONO-4538-06 studies
    Horinouchi, Hidehito
    Nishio, Makoto
    Hida, Toyoaki
    Nakagawa, Kazuhiko
    Sakai, Hiroshi
    Nogami, Naoyuki
    Atagi, Shinji
    Takahashi, Toshiaki
    Saka, Hideo
    Takenoyama, Mitsuhiro
    Katakami, Nobuyuki
    Tanaka, Hiroshi
    Takeda, Koji
    Satouchi, Miyako
    Isobe, Hiroshi
    Maemondo, Makoto
    Goto, Koichi
    Hirashima, Tomonori
    Minato, Koichi
    Sumiyoshi, Naoki
    Tamura, Tomohide
    CANCER MEDICINE, 2019, 8 (11): : 5183 - 5193
  • [46] Monotherapy with docetaxel in previously treated patients with advanced non-small cell lung carcinoma
    Courousis, C
    Androulakis, N
    Heras, P
    Vamvakas, I
    Metaxaris, G
    Souklakos, J
    Vlastos, F
    Dimadi, M
    Vossos, A
    Aravosita, P
    Georgopoulou, T
    Papandreou, A
    Hatzidaki, D
    Papadakis, E
    Georgoulias, V
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 571 - 574
  • [47] Five-year follow-up from the CA209-003 study of nivolumab in previously treated advanced non-small cell lung cancer (NSCLC): Clinical characteristics of long-term survivors
    Brahmer, Julie
    Horn, Leora
    Jackman, David
    Spigel, David
    Antonia, Scott
    Hellmann, Matthew
    Powderly, John
    Heist, Rebecca
    Sequist, Lecia
    Smith, David C.
    Leming, Philip
    Geese, William J.
    Yoon, Dennis
    Li, Ang
    Gettinger, Scott
    CANCER RESEARCH, 2017, 77
  • [48] Nivolumab monotherapy in patients with previously treated advanced non-small cell lung cancer (NSCLC) in routine clinical practice in a Spanish center
    Mielgo, X.
    Toro, P.
    Ruiz-Gimenez, L.
    Olier, C.
    Perez, M.
    Rosero, A.
    Camara, J. C.
    Hernando, S.
    Hurtado, A.
    Jara, C.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S135 - S135
  • [49] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Dragnev, K. H.
    Seltzer, M.
    Rigas, J. R.
    DiSalvo, W. M.
    Simeone, S.
    Johnstone, D.
    Nugent, W.
    Waxman, S.
    Dmitrovsky, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [50] Longer-Term Follow-Up of a Phase 2 Study (CheckMate 063) of Nivolumab in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
    Horn, Leora
    Rizvi, Naiyer A.
    Mazieres, Julien
    Planchard, David
    Stinchcombe, Thomas E.
    Dy, Grace K.
    Antonia, Scott J.
    Lena, Herve
    Minenza, Elisa
    Mennecier, Bertrand
    Otterson, Gregory A.
    Campos, Luis T.
    Gandara, David R.
    Levy, Benjamin P.
    Nair, Suresh G.
    Zalcman, Gerard
    Wolf, Juergen
    Paik, Paul
    Li, Ang
    Xu, Dong
    Neely, Jaclyn
    Qi, Zhenhao
    Harbison, Christopher
    Lynch, Mark
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S175 - S176
12345